Axinn Expands IP and Regulatory Practice with Partner Aziz Burgy
December 16, 2015
Axinn is pleased to announce that Aziz Burgy has joined the firm as a partner in the IP Group. Mr. Burgy, who will be based in Axinn’s Washington, DC office, previously practiced as a partner at Arent Fox LLP.
"We are excited to have Aziz,” said Managing Partner James Veltrop. “He is a highly-regarded attorney who understands the need to harmonize litigation, regulatory, and business strategies. His skills in handling complex matters and his deep knowledge of the life sciences industry perfectly complement the areas in which our firm has become a recognized leader."
Mr. Burgy has over a dozen years of patent litigation experience, including over 30 pharmaceutical and medical device cases. He also has extensive experience litigating before the U.S. Patent & Trademark Office. Mr. Burgy has tried other types of patent cases in U.S. district courts and before the International Trade Commission, including those involving medical devices, Internet security, robotics, software, and GPS technology.
Mr. Burgy earned his J.D. at the University of New Hampshire School of Law and holds a Master of Biotechnology from Johns Hopkins University. Prior to attending law school, he worked at MedImmune, Inc.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
The Empty Chair in Antitrust Conspiracy Cases
Webinar
Antitrust
USC Gould/Analysis Group Global Competition Law Thought Leadership Conference
Speaking Engagement
Antitrust
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
GCR Live: Europe 2026
Speaking Engagement
Antitrust
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Axinn Partners Named to Lawdragon 500 Leading Global Litigators 2026
News
Litigation & Trials
Turning Up the Heat: Federal Circuit Sets the Temperature for pH Measurements in Precedential Opinion
Axinn Viewpoints
Intellectual Property
Axinn Represents Tecomet in Closing of Merger with Orchid Orthopedic
Deals & Cases
Antitrust
Recent Benchmarking Suits Highlight DOJ Enforcement Risks
Byline Articles
Antitrust
“Old Crime, New Code” – DOJ Outlines its Views on When Software and AI Can Facilitate Collusion
Axinn Viewpoints
Antitrust
